100% Plagiarism-Free
+1-727-416-5453

Sign In

Access your dashboard and order activity.

Forgot password?

Create Account

Register to place orders and track every step.

MSE 474

Biomaterials and Nanomedicine

University of Illinois Urbana-Champaign 3 credits Materials Science & Engineering

Course Description

Design and synthesis of polymeric biomaterials and nanobiomaterials for their applications in drug and gene delivery. Part (1) fundamental biopolymer synthesis: functional group protection and de-protection; bioconjugation; protein pegylation and design and synthesis of natural and synthetic non-degradable and degradable polymers, hydrogels, bio-inspired materials, and stimuli responsive biomaterials. Part (2) preparation of nanomedicines for drug and gene delivery: nanofabritation of micelles, nanoparticles, protein conjugates, drug conjugates, nanoencapsulates, and polymeric vesicles; in-vitro and in-vivo small-molecule, gene, and protein delivery. Impact of the chemical structures of biopolymers on the stability, biocompatibility, toxicity, and in-vitro and in-vivo efficacy; clinical translation of the resulting nanomedicines in drug delivery. 3 undergraduate hours. 3 graduate hours. Prerequisite: CHEM 236 or MSE 457; MCB 450.

Code
MSE 474
Credits
3
Subject
Materials Science & Engineering

Programs That Include This Course

Get expert help with MSE 474 Biomaterials and Nanomedicine

Our subject experts help with essays, research papers, case studies, discussion posts, and capstone projects for these programs β€” written from scratch to your course requirements.

Get Help Now

Program and course information is reproduced from each university's published academic catalog for informational purposes and may change. Always confirm current requirements with your university. We are an independent academic support service and are not affiliated with or endorsed by the universities listed.

Academic Resources

Latest from the Blog

Expert guides on essay writing, citation styles, study skills, and academic success.

View All Articles